CSL Share Price Performance
AU$0
-254.00 (-100.00%)
Price AU$0
Fair ValueAU$228.58
Share Pricen/a
CSL Limited Stock Price
- 4 Narratives written by author
- 0 Comments on narratives written by author
- 458 Fair Values set on narratives written by author
CSL Community Narratives
AN
Fair Value AU$228.58 34.4% undervalued intrinsic discount
CSL: Share Price Correction Will Present Opportunity As Vaccine Uncertainty Eases
2users have liked this narrative
0users have commented on this narrative
150users have followed this narrative
AN
Fair Value AU$180.87 17.1% undervalued intrinsic discount
Seqirus Demerger And Cost Savings Will Shape A Steady Long Term Outlook
0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
MA
Fair Value AU$239.81 37.4% undervalued intrinsic discount
CSL will thrive with an 18% profit surge ahead
0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
CSL will thrive with an 18% profit surge ahead
this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spamRead more
74
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
MA
AU$239.81
37.4% undervalued intrinsic discount
martyspammer's Fair Value
Revenue
6.48% p.a.
Profit Margin
18.04%
Future PE
28.04x
Price in 2030
AU$328.55
CSL: Share Price Correction Will Present Opportunity As Vaccine Uncertainty Eases
Key Takeaways Operational transformation and investment in innovation are expected to drive margin expansion, earnings growth, and faster introduction of high-value therapies. Market expansion, a focused business structure, and strong demand for plasma and specialty products support sustainable top-line growth and premium positioning.Read more
2.2k
users have viewed this narrative2users have liked this narrative
0users have commented on this narrative
150users have followed this narrative
AN
AU$228.58
34.4% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
4.16% p.a.
Profit Margin
21.59%
Future PE
25.49x
Price in 2029
AU$281.63
Seqirus Demerger And Cost Savings Will Shape A Steady Long Term Outlook
Catalysts About CSL CSL is a global biopharmaceutical group focused on plasma therapies, vaccines and specialty medicines addressing rare and serious diseases. What are the underlying business or industry changes driving this perspective?Read more
155
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
AN
AU$180.87
17.1% undervalued intrinsic discount
AnalystLowTarget's Fair Value
Revenue
2.87% p.a.
Profit Margin
22.07%
Future PE
20.16x
Price in 2029
AU$222.83
Margin Recovery And Operating Model Simplification Will Support A Stronger Long Term Outlook
Catalysts About CSL CSL is a global biopharmaceutical group focused on plasma derived therapies, vaccines and specialty medicines for rare and serious diseases. What are the underlying business or industry changes driving this perspective?Read more
365
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
AU$289.37
48.2% undervalued intrinsic discount
AnalystHighTarget's Fair Value
Revenue
5.76% p.a.
Profit Margin
24.02%
Future PE
25.95x
Price in 2029
AU$354.53
Trending Discussion
Recently Updated Narratives
MA
CSL will thrive with an 18% profit surge ahead
Fair Value: AU$239.81 37.4% undervalued intrinsic discount
4 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
CSL: Share Recovery Will Be Supported By Execution And Recent Upgrade
Fair Value: AU$228.58 34.4% undervalued intrinsic discount
150 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Seqirus Demerger And Cost Savings Will Shape A Steady Long Term Outlook
Fair Value: AU$180.87 17.1% undervalued intrinsic discount
5 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
CSL Limited Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Aug 18, 2026
- 2.90
- 51.87%
- 9.06%
- 54.4%
About CSL
- Founded
- 1916
- Employees
- 29904
- CEO
- WebsiteView website
CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment manufactures, markets, and distributes plasma products, gene therapies, and recombinants. This segment also offers therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. The CSL Seqirus segment manufactures, markets, and distributes influenza related products and pandemic services to governments. The CSL Vifor segment manufactures, markets, and distributes products in the therapeutic areas of iron deficiency and nephrology. It also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.
